Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gelavizh Rostaminasab"'
Autor:
Zeinab Mousavi, Masood Bagheri, Gelavizh Rostaminasab, Abdolhamid Mikaeili, Ali R. Djalilian, Leila Rezakhani
Publikováno v:
Heliyon, Vol 10, Iss 20, Pp e39398- (2024)
Millions globally suffer from visual impairment, complicating the management of eye diseases due to various ocular barriers. The eye's complex structure and the limitations of existing treatments have spurred interest in tissue engineering (TE) as a
Externí odkaz:
https://doaj.org/article/8b7fe9c102b74166a0739e7e334233e3
Autor:
Ali Jafari MD, Keyvan Karimabadi MD, Aso Rahimi MD, Gelavizh Rostaminasab PhD, Mozafar Khazaei PhD, Leila Rezakhani PhD, Touraj Ahmadi jouybari MD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 22 (2023)
A significant number of cancer-related deaths are recorded globally each year, despite attempts to cure this illness. Medical science is working to develop new medication therapies as well as to find ways to identify this illness as early as possible
Externí odkaz:
https://doaj.org/article/8dd20896209f4836ab9114aae1bb9c92
Publikováno v:
International Immunopharmacology. 120:110273
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::caf1e216ad266226d4675f05ea6dca00
https://doi.org/10.1016/j.intimp.2023.110273
https://doi.org/10.1016/j.intimp.2023.110273
Publikováno v:
Medical oncology (Northwood, London, England). 40(1)
Chemotherapy drugs are the first line of cancer treatment, but problems such as low intratumoral delivery, poor bioavailability, and off-site toxicity must be addressed. Cancer-specific drug delivery techniques could improve the therapeutic outcome i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c97afa738bab4a09cf407ac70f433d4
https://pubmed.ncbi.nlm.nih.gov/36460860
https://pubmed.ncbi.nlm.nih.gov/36460860